Cory Berkland
Affiliations: | Bioengineering | University of Kansas, Lawrence, KS, United States |
Area:
Biomedical Engineering, Pharmaceutical Chemistry, NanotechnologyGoogle:
"Cory Berkland"Children
Sign in to add traineeKyle D Apley | grad student | 2018- | University of Kansas (Chemistry Tree) |
Carl J. Plumley | grad student | 2008 | University of Kansas |
Supang Khondee | grad student | 2011 | University of Kansas |
Warangkana Pornputtapitak | grad student | 2014 | University of Kansas |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Apley KD, Griffith AS, Downes GM, et al. (2023) CD22L Conjugation to Insulin Attenuates Insulin-Specific B Cell Activation. Bioconjugate Chemistry |
Johnson SN, Brucks SD, Apley KD, et al. (2023) Multivalent Scaffolds to Promote B cell Tolerance. Molecular Pharmaceutics |
Chakravarti AR, Groer CE, Gong H, et al. (2023) Design of a Tumor Binding GMCSF as Intratumoral Immunotherapy of Solid Tumors. Molecular Pharmaceutics |
Huang A, Kurhade SE, Ross P, et al. (2022) Disrupting N-Glycosylation Using Type I Mannosidase Inhibitors Alters B-Cell Receptor Signaling. Acs Pharmacology & Translational Science. 5: 1062-1069 |
Apley KD, Laflin AD, Johnson SN, et al. (2021) Optimized Production of Fc Fusion Proteins by Sortase Enzymatic Ligation. Industrial & Engineering Chemistry Research. 60: 16839-16853 |
Apley KD, Griffin JD, Johnson SN, et al. (2020) Tetrameric Fluorescent Antigen Arrays for Single-Step Identification of Antigen-Specific B Cells. Journal of Visualized Experiments : Jove |
Groer C, Zhang T, Lu R, et al. (2020) Intratumoral cancer chemotherapy with a carrier-based immunogenic cell death eliciting platinum (IV) agent. Molecular Pharmaceutics |
Leon MA, Firdessa-Fite R, Ruffalo JK, et al. (2019) Soluble Antigen Arrays Displaying Mimotopes Direct the Response of Diabetogenic T Cells. Acs Chemical Biology |
Lu R, Groer C, Kleindl PA, et al. (2019) Formulation and preclinical evaluation of a toll-like receptor 7/8 agonist as an anti-tumoral immunomodulator. Journal of Controlled Release : Official Journal of the Controlled Release Society |
Pickens CJ, Christopher MA, Leon MA, et al. (2019) Antigen-Drug Conjugates as a Novel Therapeutic Class for the Treatment of Antigen-Specific Autoimmune Disorders. Molecular Pharmaceutics |